Lesson plan
FAUC50
{{Chembox | ImageFile = FAUC50.svg | ImageSize = 250px | PIN = 5-[(1R)-2-{[2-(4-{3-[(2-Aminoethyl)disulfanyl]propoxy}-3-methoxyphenyl)ethyl]amino}-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one | OtherNames = | Section1 = | Section2 = | Section3 = }} FAUC50 is a covalent agonist that was used to obtain a bound structure of the β 2 adrenoceptor, by designing a mutant form of the receptor with an amino acid residue that would react with it. It has been used as a template for covalent agonists of other receptors, and to obtain structures.
Article summary
{{Chembox | ImageFile = FAUC50.svg | ImageSize = 250px | PIN = 5-[(1R)-2-{[2-(4-{3-[(2-Aminoethyl)disulfanyl]propoxy}-3-methoxyphenyl)ethyl]amino}-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one | OtherNames = | Section1 = | Section2 = | Section3 = }} FAUC50 is a covalent agonist that was used to obtain a bound structure of the β 2 adrenoceptor, by designing a mutant form of the receptor with an amino acid residue that would react with it. It has been used as a template for covalent agonists of other receptors, and to obtain structures.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.